A randomized trial of antioxidants in the primary prevention of Alzheimer disease warranted?

Alzheimer Disease and Associated Disorders

Volumn 10, Issue SUPPL. 1, 1996, Pages 45-49

  Evans, Denis A ^a   Morris, Martha Clare ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Antioxidant nutrients; Primary prevention trial

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; SELENIUM;

ALZHEIMER DISEASE; CANCER; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; DISEASE SEVERITY; HUMAN; NUTRIENT; OXIDATION; PATHOGENESIS; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; STROKE;

EID: 0029812472     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199601031-00012     Document Type: Review

References (54)

1. Adams JD, Klaidman LK, Odunze IN, et al. Alzheimer's and Parkinson's disease brain levels of glutathione, glutathione disulfide and vitamin E. Mol Chem Neuropathol 1991;14:213-26.
2. Agbayewa MO, Bruce VM, Siemens V. Pyridoxine, ascorbic acid and thiamine in Alzheimer and comparison subjects. Can J Psychiatry 1992;37:661-2.
3. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
4. Ambani LM, Van Woert MN, Murphy S. Brain peroxidase and catalase in Parkinson's disease. Arch Neurol 1975;32:114-8.
5. Bellomo G, Mirabelli F. Oxidative stress and cytoskeletal alterations. Ann NY Acad Sci 1993;663:97-109.
6. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. JNCI 1993;85:1483-92.
7. Buring JE, Hennekens CH. The Women's Health Study: summary of the study design. Myocardial Ischemia 1992;4:27-9.
8. Connor JR, Snyder BS, Beard JL, et al. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 1992;31:327-35.
9. Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114:1953-75.
10. Dexter DT, Carter CJ, Wells FR, et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989;52:381-9.
11. Dyrks T, Dyrks E, Hartmann T, et al. Amyloidogenicity of A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 1992;267:18210-7.
12. Dyrks T, Dyrks E, Masters CL, et al. Amyloidogenicity of rodent and human A4 sequences. Eur J Biochem Sci 1993;324:231-6.
13. Evans DA, Scherr PA, Cook NR, et al. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q 1990;68:267-89.
14. Floyd RA. Oxidative damage to behavior during aging. Science 1991;254:1597.
15. Frudenheim JL, Graham S. Toward a dietary prevention of cancer. Epidemiol Rev 1989;11:229-35.
16. Gaziano JM, Manson JE, Branch LG, et al. A prospective study of β-carotene in fruits and vegetables and decreased cardiovascular mortality in the elderly [Abstract]. Am J Epidemiol 1992;136:985.
17. Gaziano JM, Manson JE, Buring JE, et al. Dietary antioxidants and cardiovascular disease. Ann NY Acad Sci 1992;669:249-59.
18. Good BS, Perl DP, Bierer LM, et al. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimeris disease: a laser microbe (LAMMA) study. Ann Neurol 1992;31:286-92.
19. Graham S. Toward a dietary prevention of cancer. Epidemiol Rev 1983;5:38-50.
20. Grundke-Iqbal I, Fleming J, Tung YC, et al. Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol 1990;81:105-10.
21. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994;264:1772-5.
22. Hajimohammadreza I, Brammer M. Brain membrane fluidity and lipid peroxidation in Alzheimer's disease. Neurosci Lett 1990;112:333-7.
23. Halliwell B. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinsonís disease, traumatic injury or stroke? Acta Neurol Scand 1989;126:23-33.
24. Hancock MR, Hullin RP, Aylard PR, et al. Nutritional state of elderly women on admission to mental hospital. Br J Psychiatry 1985;147:404-7.
25. Hennekens CH. Micronutrients and cancer prevention. N Engl J Med 1986;315:1288-9.
26. Hennekens CH, Buring JE. Antioxidant vitamins-benefits not yet proved. N Engl J Med 1994;330:1080-1.
27. Hennekens CH, Eberlein K. A randomized trial of aspirin and β-carotene among U.S. physicians. Prev Med 1985;14:165-8.
28. Hennekens CH, Stampfer MJ, Willett W. Micronutrients and cancer chemoprevention. Cancer Detect Prev 1984;7:147-58.
29. Jackson CV, Holland AJ, Williams CA, et al. Vitamin E and Alzheimer's disease in subjects with Down's syndrome. J Ment Defic Res 1988;32:479-84.
30. Jeandel C, Nicolas MB, Dubois F, et al. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 1989;35:275-82.
31. Jenner P. Oxidative damage in neurodegenerative disease. Lancet 1994;344:796-8.
32. Kemm JR, Alcock J. The distribution of supposed indicators of nutritional status in elderly patients. Age Aging 1984;13:21-8.
33. Knekt P, Reunanen A, Järvinen R, et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-9.
34. Meocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994;36:747-51.
35. Metcalfe T, Bowen DM, Muller DPR. Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians and controls. Neurochem Res 1989;14:1209-12.
36. Mullaart E, Boerrigter METI, Ravid R, et al. Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol Aging 1990;11:169-73.
37. Nes M, Sem SW, Rousseau B, et al. Dietary intakes and nutritional status of old people with dementia living in Oslo. Eur J Clin Nutr 1988;42:581-93.
38. Pappolla MA, Omar RA, Kim KS, et al. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am J Pathol 1992;140:-621-8.
39. Pillari SR, Traber MG, Steiss JE, et al. Alpha-tocopherol concentrations of the nervous system and selected tissues of adult dogs fed three levels of vitamin E. Lipids 1993;28:1101-5.
40. Poirier J, Barbeau A. Erythrocyte antioxidant activity in human patients with Parkinson's disease. Neurosci Lett 1987;75:345-8.
41. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
42. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
43. Sato K, Saito H, Katsuki H. Synergism of tocopherol and ascorbate of the survival of cultured brain neurones. Neuroreport 1993;4:1179-82.
44. Schorah CJ, Morgan DB, Hullin RP. Plasma vitamin C concentrations in patients in a psychiatric hospital. Hum Nutr Clin Nutr 1983;37:447-52.
45. Singh S, Mulley GP, Losowsky MS. Carotenaemia in Alzheimer's disease. Br Med J 1988;297:458-9.
46. Spector R. Vitamin homeostasis in the central nervous system. N Engl J Med 1977-296:1393-8.
47. Spector R, Eells J. Deoxynucleoside and vitamin transport into the central nervous system. Fed Proc 1984;43:196-200.
48. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9.
49. Subbarao KV, Richardson JS, Ang LC. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 1990;55:342-5.
50. Thomas DE, Chung-A-On KO, Dickerson JW. Tryptophan and nutritional status of patients with senile dementia. Psychol Med 1986;16:297-305.
51. Troncoso JC, Costello A, Watson AL, et al. In vitro polymerization of oxidized tau into filaments. Brain Res 1993;613:313-6.
52. Vatassery GT, Brin MF, Fahn S, et al. Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats. J Neurochem 1988;51:621-3.
53. Volicer L, Crino PB. Involvement of free radicals in dementia of the Alzheimer type; a hypothesis. Neurobiol Aging 1990;11:567-71.
54. Zaman Z, Roche S, Fielden P, et al. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Aging 1992;21:91-4.